URL of this page: https://medlineplus.gov/druginfo/natural/999.html


What is it?

Beta-carotene is one of a group of red, orange, and yellow pigments called carotenoids. Beta-carotene and other carotenoids provide approximately 50% of the vitamin A needed in the American diet. Beta-carotene can be found in fruits, vegetables, and whole grains. It can also be made in a laboratory.

Beta-carotene is used to prevent certain cancers, heart disease, cataracts, osteoarthritis, and age related macular degeneration (AMD). It is also used to treat chronic fatigue syndrome, aging skin, AIDS, alcoholism, Alzheimer's disease, depression, diabetes, epilepsy, headache, heartburn, a bacterial infection that may cause ulcers (Helicobacter pylori infection), high blood pressure, infertility, Parkinson's disease, rheumatoid arthritis, schizophrenia, stroke, and skin disorders including psoriasis and vitiligo. It is used to reduce symptoms of breathing disorders such as asthma and exercise-induced asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). It is also used to improve memory and muscle strength. Some people use beta-carotene to reduce toxicity associated with chemotherapy, including the development of white patches or swelling and ulcers that occur inside the mouth. It is also taken by mouth to prevent the development of new moles on the skin, death due to long-term liver disease, a disease called amyotrophic lateral sclerosis (ALS), and the enlargement of a blood vessel located near the abdomen (abdominal aneurysm).

Beta-carotene is also in used in malnourished (underfed) women to reduce the chance of death and night blindness during pregnancy, as well as diarrhea and fever after giving birth.

Some people take beta-carotene by mouth to prevent sunburn. Also, people take beta-carotene by mouth to prevent sensitivity to sunlight resulting from certain diseases such as erythropoietic protoporphyria (EPP) or polymorphous light eruption.

There are many authorities - including the American Heart Association, the American Cancer Society, the World Cancer Research Institute in association with the American Institute for Cancer Research, and the World Health Organization's International Agency for Research on Cancer - that recommend getting beta-carotene and other antioxidants from food instead of supplements, at least until research finds out whether supplements offer the same benefits. Eating five servings of fruits and vegetables daily provides 6-8 mg of beta-carotene.

How effective is it?

Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, Ineffective, and Insufficient Evidence to Rate.

The effectiveness ratings for BETA-CAROTENE are as follows:

Effective for...

  • Treating sun sensitivity in people who have a form of inherited blood disorder called "erythropoietic protoporphyria." Taking beta-carotene by mouth can reduce sensitivity to the sun in people with erythropoietic protoporphyria.

Possibly effective for...

  • An eye disease called age-related macular degeneration (AMD). Taking beta-carotene by mouth along with vitamin C, vitamin E, and zinc seems to help prevent vision loss and worsening of AMD in people with more severe AMD. Taking this combination might reduce the progression of AMD to a more advanced state in people at low risk, but results are conflicting. Taking beta-carotene plus antioxidants but without zinc does not seem to improve advanced AMD. There is conflicting evidence about whether taking beta-carotene as part of the diet helps reduce the risk of developing AMD.
  • Breast cancer. Eating more fruits and vegetable that contain beta-carotene seems decrease the risk of breast cancer in pre-menopausal women who are at high risk of getting breast cancer. These include women with a family history of breast cancer and those who use alcohol excessively.
  • Preventing complications post-childbirth. Taking beta-carotene by mouth before, during, and after pregnancy seems to reduce the incidence of diarrhea and fever after childbirth.
  • Pregnancy-related complications. Taking beta-carotene by mouth seems to reduce the risk of pregnancy-related death, pregnancy-related night blindness, and post-childbirth diarrhea and fever in underfed women.
  • Sunburn. Taking beta-carotene by mouth may decrease sunburn in people sensitive to the sun. However, taking beta-carotene is unlikely to have much effect on sunburn risk in most people. Also, beta-carotene does not appear to reduce the risk of skin cancer or other skin disorders associated with sun exposure.

Possibly ineffective for...

  • Preventing abdominal aortic aneurysm, or the enlargement of a large vessel running through the abdomen. Research suggests that taking beta-carotene by mouth for about 5.8 years does not prevent the development of abdominal aortic aneurysm in male smokers.
  • Alzheimer's disease. Eating a diet that contains a higher amount of beta-carotene does not seem to reduce the risk of Alzheimer's disease.
  • Cataracts. Taking beta-carotene alone or in combination with vitamin C, vitamin E, and zinc, for up to 8 years is unlikely to reduce the incidence or progression of cataracts.
  • Cystic fibrosis. Taking beta-carotene by mouth for up to 14 months does not improve lung function in people with cystic fibrosis.
  • Diabetes. Some early research suggests that eating a diet containing higher amounts of beta-carotene is linked with a reduced risk of developing type 2 diabetes. However, taking beta-carotene supplements does not reduce the risk of developing diabetes or diabetes-related complications.
  • Moles. Research shows that taking beta-carotene by mouth for 3 years does not reduce the development of new moles.
  • Liver cancer. Taking beta-carotene alone or with vitamin E for 5-8 years does not prevent liver cancer in men who smoke.
  • Liver disease. Taking beta-carotene alone or with vitamin E for 5-8 years does not prevent death due to liver disease in men who smoke.
  • Overall risk of death. Some research suggests that taking supplements containing beta-carotene, vitamin C, vitamin E, selenium, and zinc for about 7 years might lower the risk of death in men. However, it doesn't seem to benefit women. Also, other research shows that taking larger doses of beta-carotene in for up to 12 years may increase the risk of death in both men and women.
  • Stroke. Taking beta-carotene by mouth for about 6 years does not reduce the risk of stroke in male smokers. Also, there is some evidence that taking beta-carotene supplements increases the risk of bleeding in the brain in people who drink alcohol.

Likely ineffective for...

  • Cancer. Most research shows that taking beta-carotene does not prevent or decrease death from uterine cancer, cervical cancer, thyroid cancer, bladder cancer, skin cancers, brain cancer, or blood cancer (leukemia). However, some research suggests a combination of beta-carotene with vitamin C, vitamin E, selenium, and zinc might lower cancer rates in men, but not women. Researchers speculate that men have lower intake of dietary antioxidants and therefore might benefit more from supplements.
  • Heart disease. A Science Advisory from the American Heart Association states that the evidence does not justify use of antioxidants such as beta-carotene for reducing the risk of heart disease. Evidence also shows that beta-carotene in combination with vitamin C and E does not decrease heart disease risk.
  • Colon cancer. Most research shows that taking beta-carotene by mouth, alone or with vitamins C and E, selenium, and calcium carbonate, does not decrease the risk of colon tumor growth. It also doesn't seem to reduce the risk of colon tumor recurrence in people who have had colon tumors removed, although it might reduce the risk of colon tumor recurrence in people who never drink or smoke. However, in people that smoke cigarettes and drink alcohol, taking beta-carotene supplements increases the risk of new tumors. It is unclear if dietary beta-carotene reduces the risk of colon cancer.
  • Lung cancer. Taking beta-carotene seems to increase the risk of lung cancer in people who smoke, people who used to smoke, people exposed to asbestos, and those who use alcohol in addition to smoking. However, beta-carotene from food does not seem to have this adverse effect. Taking supplements containing beta-carotene, vitamin E, and selenium for about 5 years does not reduce the risk of death in people previously diagnosed with lung cancer.
  • Prostate cancer. Taking beta-carotene supplements does not prevent prostate cancer in most men. In fact, there is some concern that beta-carotene supplements might actually increase the risk of prostate cancer in some men. There is evidence that men who take a multivitamin daily along with a separate beta-carotene supplement have an increased risk of developing advanced prostate cancer. Also, men who smoke and take beta-carotene supplements have in increased risk of developing prostate cancer.

Insufficient evidence to rate effectiveness for...

  • Aging skin. Early research shows that taking 30 mg of beta-carotene daily may reduce signs of skin aging. However, taking 90 mg of beta-carotene daily doesnt have any benefit.
  • Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease). Taking beta-carotene supplements doesn't seem to reduce the risk of ALS. However, eating a diet high in beta-carotene seems to reduce the risk of ALS.
  • Asthma. Eating a diet high in beta-carotene does not seem to be linked with a reduced risk of asthma.
  • Side effects from chemotherapy. Eating a diet high in beta-carotene is linked with reduced toxic effects in children undergoing chemotherapy for a blood cancer called lymphoblastic leukemia.
  • Preventing complications of lung disease (chronic obstructive pulmonary disease, COPD). Eating more beta-carotene in the diet seems to help prevent bronchitis and difficulty breathing in smokers with COPD. But beta-carotene supplements do not.
  • Mental performance. Some research suggests that taking beta-carotene for one year does not improve thinking skills and memory in older men. However, taking beta-carotene for up to 18 years may improve these outcomes.
  • Esophageal cancer. Taking beta-carotene supplements alone or in combination with vitamin A or vitamin E plus vitamin C doesn't seem to reduce the risk of esophageal cancer.
  • Asthma attacks triggered by exercise. Taking beta-carotene by mouth seems to prevent asthma attacks that are triggered by exercise.
  • Stomach cancer. Some research suggests that taking beta-carotene does not decrease risk of stomach cancer. Also, taking beta-carotene in combination with vitamins A, C, and/or E does not seem to reduce the risk of stomach cancer. However, some early research suggests that taking beta-carotene, vitamin E, and selenium might reduce the risk of stomach cancer in underfed, Chinese people who are at high risk. Also, taking beta-carotene seems to help treat precancerous lesions in the stomach in people at risk for stomach cancer.
  • Helicobacter pylori (H pylori) infection, which causes stomach ulcers. Taking beta-carotene by mouth, in combination with prescription drugs, does not help treat H. pylori infection better than prescription drugs alone.
  • HIV/AIDS. Some early research suggests that taking beta-carotene by mouth for 4 weeks helps improve immune system function in people with HIV. However, conflicting evidence exists.
  • White patches on the tongue and mouth called oral leukoplakia. It is unclear if taking beta-carotene by mouth decreases symptoms of oral leukoplakia. Some research suggests that it might when taken up to 12 months. However, at least in people that do not smoke, beta-carotene does not seem to help reduce symptoms or prevent mouth cancer.
  • Swelling and ulcers in the lining of the mouth (oral mucositis). Taking beta-carotene by mouth doesn't appear to prevent the development of oral mucositis during radiation therapy or chemotherapy.
  • Osteoarthritis. Higher dietary intake of beta-carotene may prevent osteoarthritis from getting worse, but it does not seem to prevent osteoarthritis.
  • Ovarian cancer. Eating a diet rich in carotenoids, including beta-carotene, may reduce the risk of ovarian cancer in women after menopause.
  • Pancreatic cancer. Taking beta-carotene supplements alone or in combination with other antioxidants such as vitamin A or vitamin E doesn't seem to reduce the risk of pancreatic cancer.
  • Physical performance. Eating a diet that contains a higher amount of beta-carotene seems to improve physical performance and muscle strength in older people.
  • A skin rash due to sun sensitivity called polymorphous light eruption. Some research suggests that taking beta-carotene by mouth can improve sensitivity to sun exposure in people with polymorphous light eruptions. However, conflicting research exists.
  • Alcoholism.
  • Chronic fatigue syndrome (CFS).
  • Depression.
  • Epilepsy.
  • Headaches.
  • Heartburn.
  • Hypertension.
  • Infertility.
  • Parkinson's disease.
  • Psoriasis.
  • Rheumatoid arthritis.
  • Schizophrenia.
  • Other conditions.
More evidence is needed to rate beta-carotene for these uses.

How does it work?

Beta-carotene is converted to vitamin A, an essential nutrient. It has antioxidant and anti-inflammatory activity, which help to protect cells from damage.

Are there safety concerns?

Beta-carotene is LIKELY SAFE in adults and children when taken by mouth in appropriate amounts for certain specific medical conditions. However, beta-carotene supplements are not recommended for general use.

Beta-carotene is POSSIBLY UNSAFE when taken by mouth in high doses, especially when taken long-term. High doses of beta-carotene can turn skin yellow or orange.

There is growing concern that taking high doses of antioxidant supplements such as beta-carotene might do more harm than good. Some research shows that taking high doses of beta-carotene supplements might increase the chance of death from all causes, increase the risk of certain cancers, and possibly other serious side effects. In addition, there is also concern that taking large amounts of a multivitamin plus a separate beta-carotene supplement increases the chance of developing advanced prostate cancer in men.

Special precautions & warnings:

Pregnancy and breast-feeding: Beta-carotene is LIKELY SAFE when taken by mouth in appropriate amounts. However, large doses of beta-carotene supplements are not recommended for general use during pregnancy and breast-feeding.

Angioplasty, a heart procedure: There is some concern that when antioxidant vitamins, including beta-carotene, are used together they might have harmful effects after angioplasty. They can interfere with healing. Don't use beta-carotene and other antioxidant vitamins before or after angioplasty without the recommendation of your healthcare provider.

History of asbestos exposure: In people who have been exposed to asbestos, beta-carotene supplements might increase the risk of cancer. Dont take beta-carotene supplements if you have been exposed to asbestos.

Smoking. In people who smoke, beta-carotene supplements might increase the risk of colon, lung, and prostate cancer. Don't take beta-carotene supplements if you smoke.

Are there interactions with medications?

Be cautious with this combination.
Medications used for lowering cholesterol (Statins)
Taking beta-carotene, selenium, vitamin C, and vitamin E together might decrease the effectiveness of some medications used for lowering cholesterol. It is not known if beta-carotene alone decreases the effectiveness of all medications used for lowering cholesterol.

Some medications used for lowering cholesterol include atorvastatin (Lipitor), fluvastatin (Lescol), lovastatin (Mevacor), and pravastatin (Pravachol).
Niacin can increase good cholesterol levels. Taking beta-carotene along with vitamin E, vitamin C, and selenium might decrease the effects of niacin on good cholesterol levels.

Are there interactions with herbs and supplements?

There are no known interactions with herbs and supplements.

Are there interactions with foods?

Drinking excessive amounts of alcohol can reduce the level of beta-carotene in the body and increase the level of another chemical called retinol. Researchers are concerned that this might increase the risk of cancer. But more research is needed to find out whether this concern is justified.
Olestra (fat substitute)
Olestra may interfere with the action of beta-carotene in the body. Olestra lowers serum beta-carotene concentrations in healthy people by 27%.

What dose is used?

The following doses have been studied in scientific research:


  • For erythropoietic protoporphyria (EPP): 180 mg of beta-carotene per day has been used. If this dose is not effective, the dose can be increased to 300 mg per day.
  • For preventing sunburn in sun-sensitive people: A specific product (Betatene by Betatene Ltd or Cognis Australia Pty. Ltd) containing 24-25 mg of beta-carotene along with other carotenoids has been used for 12 weeks.
  • For treating age-related macular degeneration (AMD): 15 mg of beta-carotene plus 500 mg of vitamin C, and 400 IU of vitamin E, with or without 80 mg of zinc oxide, has been used daily.
  • For preventing complications after childbirth: 42 mg of beta-carotene weekly
  • For pregnancy-related complications: increasing calcium consumption from dairy products to a total intake of 500-2400 mg/day in combination with a calorie-restricted diet has been used.

  • For erythropoietic protoporphyria (EPP): Dosage is based on age. For age 1 to 4, the daily dose is 60-90 mg; age 5 to 8 years, 90-120 mg; age 9 to 12 years, 120-150 mg; age 13 to 16 years, 150-180 mg; and age 16 and older, 180 mg. If people still remain too sensitive to the sun using these doses, beta-carotene can be increased by 30-60 mg per day for children under 16 years old, and up to a total of 300 mg per day for people older than age 16.
The recommended daily intake of beta-carotene has not been set because there hasn't been enough research.

Beta-carotene supplements are available in two forms. One is water-based, and the other is oil-based. Studies show that the water-based version seems to be absorbed better.

Other names

A-Beta-Carotene, A-Bêta-Carotène, Beta Carotene, Bêta-Carotène, Bêta-Carotène Tout Trans, Beta-Caroteno, Carotenes, Carotènes, Carotenoids, Caroténoïdes, Caroténoïdes Mélangés, Mixed Carotenoids, Provitamin A, Provitamine A.


To learn more about how this article was written, please see the Natural Medicines Comprehensive Database methodology.


  1. Ribeiro BD, Barreto DW, Coelho MAZ. Technological Aspects of ß-Carotene Production. Food Bioprocess Technol 2011;4:693-701.
  2. Paiva SA, Russell RM. Beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr. 1999;18:426-33. View abstract.
  3. Hernandez-Alvarez E, Pérez-Sacristán BI, Blanco-Navarro I, Donoso-Navarro E, Silvestre-Mardomingo RA, Granado-Lorencio F. Analysis of microsamples of human faeces: a non-invasive approach to study the bioavailability of fat-soluble bioactive compounds. Eur J Nutr. 2015 Dec;54:1371-8. View abstract.
  4. Nagao T, Warnakulasuriya S, Nakamura T, Kato S, Yamamoto K, Fukano H, Suzuki K, Shimozato K, Hashimoto S. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial. Int J Cancer. 2015 Apr 1;136:1708-17. View abstract.
  5. Lai GY, Weinstein SJ, Taylor PR, McGlynn KA, Virtamo J, Gail MH, Albanes D, Freedman ND. Effects of a-tocopherol and ß-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study. Br J Cancer. 2014 Dec 9;111:2220-3. View abstract.
  6. Santos VM, Camilo AG, Souza LA, Souza DW, Marinho CS, Monteiro LM. A woman with treated breast cancer, recent neurological symptoms and xanthoderma. Acta Med Iran. 2013 Apr 6;51:195-8.
  7. Cho S, Lee DH, Won CH, Kim SM, Lee S, Lee MJ, Chung JH. Differential effects of low-dose and high-dose beta-carotene supplementation on the signs of photoaging and type I procollagen gene expression in human skin in vivo. Dermatology. 2010;221:160-71. View abstract.
  8. Wang A, Han J, Jiang Y, Zhang D. Association of vitamin A and ß-carotene with risk for age-related cataract: a meta-analysis. Nutrition. 2014 Oct;30:1113-21. View abstract.
  9. Bjelakovic G, Nikolova D, Gluud C. Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? PLoS One. 2013 Sep 6;8:e74558. View abstract.
  10. Fitzgerald KC, O'Reilly ÉJ, Fondell E, et al. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies. Ann Neurol. 2013;73:236-45. View abstract.
  11. Michal Freedman D, Kuncl RW, Weinstein SJ, Malila N, Virtamo J, Albanes D. Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14:246-51. doi: 10.3109/21678421.2012.745570. Epub 2013 Jan 4. View abstract.
  12. Li FJ, Shen L, Ji HF. Dietary intakes of vitamin E, vitamin C, and ß-carotene and risk of Alzheimer's disease: a meta-analysis. J Alzheimers Dis. 2012;31:253-8. View abstract.
  13. Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group. Long-term effects of vitamins C and E, ß-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology. 2013 Aug;120:1604-11.e4. View abstract.
  14. Zhu S, Mason J Shi Y et al. The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers-clinical trial and follow-up for seven years. Chin J Gastroenterol 2002;7:73-78.
  15. Niebauer G., Mischer P. and Formanek I. Lightsensitive dermatoses in children. Mod.Probl.Paediatr. 1976;20:86-101.
  16. Gollnick, H. P. M. W. Hopfenmu ller C. Hemmes S. C. Chun C. Schmid K. Sundermeier and H. K. Biesalski. Systemic beta carotene plus topical UV-sunscreen are an optimal protection against harmful effects of natural UV-sunlight: Results of the Berlin-Eilath study. Eur.J.Dermatol. 1996;6:200-205.
  17. Hofstad, B., Almendingen, K., Vatn, M., Andersen, S. N., Owen, R. W., Larsen, S., and Osnes, M. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 1998;59:148-156. View abstract.
  18. de Klerk, N. H., Musk, A. W., Ambrosini, G. L., Eccles, J. L., Hansen, J., Olsen, N., Watts, V. L., Lund, H. G., Pang, S. C., Beilby, J., and Hobbs, M. S. Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene. Int.J.Cancer 1-30-1998;75:362-367. View abstract.
  19. Sankaranarayanan, R., Mathew, B., Varghese, C., Sudhakaran, P. R., Menon, V., Jayadeep, A., Nair, M. K., Mathews, C., Mahalingam, T. R., Balaram, P., and Nair, P. P. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol. 1997;33:231-236. View abstract.
  20. Mathews-Roth, M. M., Pathak, M. A., Fitzpatrick, T. B., Harber, L. H., and Kass, E. H. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Arch.Dermatol. 1977;113:1229-1232. View abstract.
  21. Goerz, G. and Ippen, H. [Treatment of photodermatoses with carotinoids (author's transl)]. Dtsch.Med.Wochenschr. 7-22-1977;102:1051-1055. View abstract.
  22. Coodley, G. O., Coodley, M. K., Lusk, R., Green, T. R., Bakke, A. C., Wilson, D., Wachenheim, D., Sexton, G., and Salveson, C. Beta-carotene in HIV infection: an extended evaluation. AIDS 1996;10:967-973. View abstract.
  23. Richer, S. Multicenter ophthalmic and nutritional age-related macular degeneration study--part 2: antioxidant intervention and conclusions. J.Am.Optom.Assoc. 1996;67:30-49. View abstract.
  24. von Laar, J., Stahl, W., Bolsen, K., Goerz, G., and Sies, H. Beta-carotene serum levels in patients with erythropoietic protoporphyria on treatment with the synthetic all-trans isomer or a natural isomeric mixture of beta-carotene. J.Photochem.Photobiol.B 1996;33:157-162. View abstract.
  25. Rapola, J. M., Virtamo, J., Haukka, J. K., Heinonen, O. P., Albanes, D., Taylor, P. R., and Huttunen, J. K. Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial. JAMA 3-6-1996;275:693-698. View abstract.
  26. Coodley, G. O., Nelson, H. D., Loveless, M. O., and Folk, C. Beta-carotene in HIV infection. J.Acquir.Immune.Defic.Syndr. 1993;6:272-276. View abstract.
  27. Li, J. Y., Taylor, P. R., Li, B., Dawsey, S., Wang, G. Q., Ershow, A. G., Guo, W., Liu, S. F., Yang, C. S., Shen, Q., and . Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J.Natl.Cancer Inst. 9-15-1993;85:1492-1498. View abstract.
  28. Wenzel, G., Kuklinski, B., Ruhlmann, C., and Ehrhardt, D. [Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy]. Z.Gesamte Inn.Med. 1993;48:490-496. View abstract.
  29. No author. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann.Epidemiol. 1994;4:1-10. View abstract.
  30. Blumberg, J. and Block, G. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland. Nutr.Rev. 1994;52:242-245. View abstract.
  31. Homnick, D. N., Spillers, C. R., Cox, S. R., Cox, J. H., Yelton, L. A., DeLoof, M. J., Oliver, L. K., and Ringer, T. V. Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosis. J.Pediatr. 1995;127:491-494. View abstract.
  32. Garmyn, M., Ribaya-Mercado, J. D., Russel, R. M., Bhawan, J., and Gilchrest, B. A. Effect of beta-carotene supplementation on the human sunburn reaction. Exp.Dermatol. 1995;4:104-111. View abstract.
  33. Novotny, J. A., Dueker, S. R., Zech, L. A., and Clifford, A. J. Compartmental analysis of the dynamics of beta-carotene metabolism in an adult volunteer. J.Lipid Res. 1995;36:1825-1838. View abstract.
  34. Hiatt, R. A., Armstrong, M. A., Klatsky, A. L., and Sidney, S. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control 1994;5:66-72. View abstract.
  35. MacLennan, R., Macrae, F., Bain, C., Battistutta, D., Chapuis, P., Gratten, H., Lambert, J., Newland, R. C., Ngu, M., Russell, A., and . Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J.Natl.Cancer Inst. 12-6-1995;87:1760-1766. View abstract.
  36. Suhonen, R. and Plosila, M. The effect of beta-carotene in combination with canthaxanthin, Ro 8-8427 (Phenoro), in treatment of polymorphous light eruptions. Dermatologica 1981;163:172-176. View abstract.
  37. Mathews-Roth, M. M. Treatment of erythropoietic protoporphyria with beta-carotene. Photodermatol. 1984;1:318-321. View abstract.
  38. Barth, J., Fickweiler, E., Harnack, K., Herrmann, K., Hubner, U., Schaarschmidt, H., and Schiller, F. [Beta-carotene treatment of protoporphyrias and polymorphic light dermatoses]. Dermatol.Monatsschr. 1984;170:244-248. View abstract.
  39. Wennersten, G. Carotenoid treatment for light sensitivity: a reappraisal and six years' experience. Acta Derm.Venereol. 1980;60:251-255. View abstract.
  40. Zaynoun, S. T., Hunter, J. A., Darby, F. J., Zarembski, P., Johnson, B. E., and Frain-Bell, W. The treatment of erythropoietic protoporphyria. Experience with beta-carotene. Br.J.Dermatol. 1977;97:663-668. View abstract.
  41. Haeger-Aronsen, B., Krook, G., and Abdulla, M. Oral carotenoids for photohypersensitivity in patients with erythrohepatic protoporphyria, polymorphous light eruptions and lupus erythematodes discoides. Int.J.Dermatol. 1979;18:73-82. View abstract.
  42. Thomsen, K., Schmidt, H., and Fischer, A. Beta-carotene in erythropoietic protoporphyria: 5 years' experience. Dermatologica 1979;159:82-86. View abstract.
  43. Baart, de la Faille, Suurmond, D., Went, L. N., van, Steveninck J., and Schothorst, A. A. -Carotene as a treatment for photohypersensitivity due to erythropoietic protoporphyria. Dermatologica 1972;145:389-394. View abstract.
  44. Lewis, M. B. The effect of -carotene on serum vitamin A levels in erythropoietic protoporphyria. Australas.J.Dermatol. 1972;13:75-78. View abstract.
  45. Mathews-Roth, M. M., Pathak, M. A., Parrish, J., Fitzpatrick, T. B., Kass, E. H., Toda, K., and Clemens, W. A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. J.Invest Dermatol. 1972;59:349-353. View abstract.
  46. Jansen, C. T. Beta-carotene treatment of polymorphous light eruptions. Dermatologica 1974;149:363-373. View abstract.
  47. Mathews-Roth, M. M., Pathak, U. A., Fitzpatrick, T. B., Harber, L. C., and Kass, E. H. Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA 5-20-1974;228:1004-1008. View abstract.
  48. Parrish, J. A., Le Vine, M. J., Morison, W. L., Gonzalez, E., and Fitzpatrick, T. B. Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruption. Br.J.Dermatol. 1979;100:187-191. View abstract.
  49. Krook, G. and Haeger-Aronsen, B. Erythrohepatic protoporphyria and its treatment with beta-carotene. Acta Derm.Venereol. 1974;54:39-44. View abstract.
  50. Swanbeck, G. and Wennersten, G. Treatment of polymorphous light eruptions with beta-carotene. Acta Derm.Venereol. 1972;52:462-466. View abstract.
  51. Weber, U. and Goerz, G. [Carotinoid retinopathy. III. Reversibility]. Klin.Monbl.Augenheilkd. 1986;188:20-22. View abstract.
  52. Philipp, W. [Carotinoid deposits in the retina]. Klin.Monbl.Augenheilkd. 1985;187:439-440. View abstract.
  53. Hennekens, C. H. and Eberlein, K. A randomized trial of aspirin and beta-carotene among U.S. physicians. Prev.Med. 1985;14:165-168. View abstract.
  54. Holzle, E., Plewig, G., von, Kries R., and Lehmann, P. Polymorphous light eruption. J.Invest Dermatol. 1987;88(3 Suppl):32s-38s. View abstract.
  55. Corbett, M. F., Herxheimer, A., Magnus, I. A., Ramsay, C. A., and Kobza-Black, A. The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial. Br.J.Dermatol. 1977;97:655-662. View abstract.
  56. Mills, E. E. The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. Br.J.Cancer 1988;57:416-417. View abstract.
  57. de, Selys R., Decroix, J., Frankart, M., Hassoun, A., Willocx, D., Pirard, C., and Bourlond, A. [Erythropoietic protoporphyria]. Ann.Dermatol.Venereol. 1988;115:555-560. View abstract.
  58. Hsing, A. W., Comstock, G. W., Abbey, H., and Polk, B. F. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl.Cancer Inst. 6-6-1990;82:941-946. View abstract.
  59. Eliassen, A. H., Hendrickson, S. J., Brinton, L. A., Buring, J. E., Campos, H., Dai, Q., Dorgan, J. F., Franke, A. A., Gao, Y. T., Goodman, M. T., Hallmans, G., Helzlsouer, K. J., Hoffman-Bolton, J., Hulten, K., Sesso, H. D., Sowell, A. L., Tamimi, R. M., Toniolo, P., Wilkens, L. R., Winkvist, A., Zeleniuch-Jacquotte, A., Zheng, W., and Hankinson, S. E. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl.Cancer Inst. 12-19-2012;104:1905-1916. View abstract.
  60. Evans, J. R. and Lawrenson, J. G. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane.Database.Syst.Rev. 2012;11:CD000254. View abstract.
  61. Cortes-Jofre, M., Rueda, J. R., Corsini-Munoz, G., Fonseca-Cortes, C., Caraballoso, M., and Bonfill, Cosp, X. Drugs for preventing lung cancer in healthy people. Cochrane.Database.Syst.Rev. 2012;10:CD002141. View abstract.
  62. Bonifant, C. M., Shevill, E., and Chang, A. B. Vitamin A supplementation for cystic fibrosis. Cochrane.Database.Syst.Rev. 2012;8:CD006751. View abstract.
  63. Miller, P. E. and Snyder, D. C. Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr.Clin.Pract. 2012;27:599-612. View abstract.
  64. Aune, D., Chan, D. S., Vieira, A. R., Navarro Rosenblatt, D. A., Vieira, R., Greenwood, D. C., and Norat, T. Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2012;96:356-373. View abstract.
  65. Thorne-Lyman, A. L. and Fawzi, W. W. Vitamin A and carotenoids during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr.Perinat.Epidemiol. 2012;26 Suppl 1:36-54. View abstract.
  66. Mathew, M. C., Ervin, A. M., Tao, J., and Davis, R. M. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane.Database.Syst.Rev. 2012;6:CD004567. View abstract.
  67. Evans, J. R. and Lawrenson, J. G. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane.Database.Syst.Rev. 2012;6:CD000253. View abstract.
  68. Li, F. J., Shen, L., and Ji, H. F. Dietary intakes of vitamin E, vitamin C, and beta-carotene and risk of Alzheimer's disease: a meta-analysis. J.Alzheimers.Dis. 2012;31:253-258. View abstract.
  69. Pabalan, N., Jarjanazi, H., Sung, L., Li, H., and Ozcelik, H. Menopausal status modifies breast cancer risk associated with the myeloperoxidase (MPO) G463A polymorphism in Caucasian women: a meta-analysis. PLoS.One. 2012;7:e32389. View abstract.
  70. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., and Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane.Database.Syst.Rev. 2012;3:CD007176. View abstract.
  71. Knekt, P., Aromaa, A., Maatela, J., Aaran, R. K., Nikkari, T., Hakama, M., Hakulinen, T., Peto, R., and Teppo, L. Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am.J.Epidemiol. 1990;132:857-870. View abstract.
  72. Biesalski, H. K., Grune, T., Tinz, J., Zollner, I., and Blumberg, J. B. Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients. 2010;2:929-949. View abstract.
  73. Galli, F., Battistoni, A., Gambari, R., Pompella, A., Bragonzi, A., Pilolli, F., Iuliano, L., Piroddi, M., Dechecchi, M. C., and Cabrini, G. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim.Biophys.Acta 2012;1822:690-713. View abstract.
  74. Lahner, E., Persechino, S., and Annibale, B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter. 2012;17:1-15. View abstract.
  75. Bolling, B. W., Chen, C. Y., McKay, D. L., and Blumberg, J. B. Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, Brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts. Nutr.Res.Rev. 2011;24:244-275. View abstract.
  76. Hsing, A. W., McLaughlin, J. K., Schuman, L. M., Bjelke, E., Gridley, G., Wacholder, S., Chien, H. T., and Blot, W. J. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 11-1-1990;50:6836-6840. View abstract.
  77. Greenberg, E. R., Baron, J. A., Stukel, T. A., Stevens, M. M., Mandel, J. S., Spencer, S. K., Elias, P. M., Lowe, N., Nierenberg, D. W., Bayrd, G., and . A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N.Engl.J.Med. 9-20-1990;323:789-795. View abstract.
  78. Zhang, X., Dai, B., Zhang, B., and Wang, Z. Vitamin A and risk of cervical cancer: a meta-analysis. Gynecol.Oncol. 2012;124:366-373. View abstract.
  79. Jeon, Y. J., Myung, S. K., Lee, E. H., Kim, Y., Chang, Y. J., Ju, W., Cho, H. J., Seo, H. G., and Huh, B. Y. Effects of beta-carotene supplements on cancer prevention: meta-analysis of randomized controlled trials. Nutr.Cancer 2011;63:1196-1207. View abstract.
  80. Hu, F., Wang, Yi B., Zhang, W., Liang, J., Lin, C., Li, D., Wang, F., Pang, D., and Zhao, Y. Carotenoids and breast cancer risk: a meta-analysis and meta-regression. Breast Cancer Res.Treat. 2012;131:239-253. View abstract.
  81. Fulan, H., Changxing, J., Baina, W. Y., Wencui, Z., Chunqing, L., Fan, W., Dandan, L., Dianjun, S., Tong, W., Da, P., and Yashuang, Z. Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression. Cancer Causes Control 2011;22:1383-1396. View abstract.
  82. Myung, S. K., Ju, W., Kim, S. C., and Kim, H. Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis. BJOG. 2011;118:1285-1291. View abstract.
  83. Bjelakovic, G., Gluud, L. L., Nikolova, D., Bjelakovic, M., Nagorni, A., and Gluud, C. Antioxidant supplements for liver diseases. Cochrane.Database.Syst.Rev. 2011;:CD007749. View abstract.
  84. Stratton, J. and Godwin, M. The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis. Fam.Pract. 2011;28:243-252. View abstract.
  85. Nurmatov, U., Devereux, G., and Sheikh, A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J.Allergy Clin.Immunol. 2011;127:724-733. View abstract.
  86. Shamseer, L., Adams, D., Brown, N., Johnson, J. A., and Vohra, S. Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane.Database.Syst.Rev. 2010;:CD007020. View abstract.
  87. Irlam, J. H., Visser, M. M., Rollins, N. N., and Siegfried, N. Micronutrient supplementation in children and adults with HIV infection. Cochrane.Database.Syst.Rev. 2010;:CD003650. View abstract.
  88. Tsiligianni, I. G. and van der Molen, T. A systematic review of the role of vitamin insufficiencies and supplementation in COPD. Respir.Res. 2010;11:171. View abstract.
  89. van den Broek, N., Dou, L., Othman, M., Neilson, J. P., Gates, S., and Gulmezoglu, A. M. Vitamin A supplementation during pregnancy for maternal and newborn outcomes. Cochrane.Database.Syst.Rev. 2010;:CD008666. View abstract.
  90. Oliveira-Menegozzo, J. M., Bergamaschi, D. P., Middleton, P., and East, C. E. Vitamin A supplementation for postpartum women. Cochrane.Database.Syst.Rev. 2010;:CD005944. View abstract.
  91. Park, Y., Spiegelman, D., Hunter, D. J., Albanes, D., Bergkvist, L., Buring, J. E., Freudenheim, J. L., Giovannucci, E., Goldbohm, R. A., Harnack, L., Kato, I., Krogh, V., Leitzmann, M. F., Limburg, P. J., Marshall, J. R., McCullough, M. L., Miller, A. B., Rohan, T. E., Schatzkin, A., Shore, R., Sieri, S., Stampfer, M. J., Virtamo, J., Weijenberg, M., Willett, W. C., Wolk, A., Zhang, S. M., and Smith-Warner, S. A. Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control 2010;21:1745-1757. View abstract.
  92. Wieringa, F. T., Dijkhuizen, M. A., Muhilal, and Van der Meer, J. W. Maternal micronutrient supplementation with zinc and beta-carotene affects morbidity and immune function of infants during the first 6 months of life. Eur.J.Clin.Nutr. 2010;64:1072-1079. View abstract.
  93. Jiang, L., Yang, K. H., Tian, J. H., Guan, Q. L., Yao, N., Cao, N., Mi, D. H., Wu, J., Ma, B., and Yang, S. H. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials. Nutr.Cancer 2010;62:719-727. View abstract.
  94. Devore, E. E., Grodstein, F., van Rooij, F. J., Hofman, A., Stampfer, M. J., Witteman, J. C., and Breteler, M. M. Dietary antioxidants and long-term risk of dementia. Arch.Neurol. 2010;67:819-825. View abstract.
  95. Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R. F., Maguire, C., Hind, D., and Tappenden, P. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol.Assess. 2010;14:1-206. View abstract.
  96. Bjelakovic, G., Gluud, L. L., Nikolova, D., Bjelakovic, M., Nagorni, A., and Gluud, C. Meta-analysis: antioxidant supplements for liver diseases - the Cochrane Hepato-Biliary Group. Aliment.Pharmacol.Ther. 2010;32:356-367. View abstract.
  97. Papaioannou, D., Cooper, K. L., Carroll, C., Hind, D., Squires, H., Tappenden, P., and Logan, R. F. Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Dis. 2011;13:1085-1099. View abstract.
  98. Kataja-Tuomola, M. K., Kontto, J. P., Mannisto, S., Albanes, D., and Virtamo, J. R. Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study. Ann.Med. 2010;42:178-186. View abstract.
  99. Hercberg, S., Kesse-Guyot, E., Druesne-Pecollo, N., Touvier, M., Favier, A., Latino-Martel, P., Briancon, S., and Galan, P. Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study. Int.J.Cancer 10-15-2010;127:1875-1881. View abstract.
  100. Druesne-Pecollo, N., Latino-Martel, P., Norat, T., Barrandon, E., Bertrais, S., Galan, P., and Hercberg, S. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int.J.Cancer 7-1-2010;127:172-184. View abstract.
  101. Perry, J. R., Ferrucci, L., Bandinelli, S., Guralnik, J., Semba, R. D., Rice, N., Melzer, D., Saxena, R., Scott, L. J., McCarthy, M. I., Hattersley, A. T., Zeggini, E., Weedon, M. N., and Frayling, T. M. Circulating beta-carotene levels and type 2 diabetes-cause or effect? Diabetologia 2009;52:2117-2121. View abstract.
  102. Rodrigues, M. J., Bouyon, A., and Alexandre, J. [Role of antioxidant complements and supplements in oncology in addition to an equilibrate regimen: a systematic review]. Bull.Cancer 2009;96:677-684. View abstract.
  103. Song, Y., Cook, N. R., Albert, C. M., Van, Denburgh M., and Manson, J. E. Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am.J.Clin.Nutr. 2009;90:429-437. View abstract.
  104. Allen, S., Britton, J. R., and Leonardi-Bee, J. A. Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis. Thorax 2009;64:610-619. View abstract.
  105. Lehmann, P., Scharffetter, K., Kind, P., and Goerz, G. [Erythropoietic protoporphyria: synopsis of 20 patients]. Hautarzt 1991;42:570-574. View abstract.
  106. Mente, A., de, Koning L., Shannon, H. S., and Anand, S. S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch.Intern.Med. 4-13-2009;169:659-669. View abstract.
  107. Garbagnati, F., Cairella, G., De, Martino A., Multari, M., Scognamiglio, U., Venturiero, V., and Paolucci, S. Is antioxidant and n-3 supplementation able to improve functional status in poststroke patients? Results from the Nutristroke Trial. Cerebrovasc.Dis. 2009;27:375-383. View abstract.
  108. Minder, E. I., Schneider-Yin, X., Steurer, J., and Bachmann, L. M. A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria. Cell Mol.Biol.(Noisy.-le-grand) 2009;55:84-97. View abstract.
  109. Satia, J. A., Littman, A., Slatore, C. G., Galanko, J. A., and White, E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am.J.Epidemiol. 4-1-2009;169:815-828. View abstract.
  110. Bjelakovic, G., Nikolova, D., Simonetti, R. G., and Gluud, C. Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment.Pharmacol.Ther. 9-15-2008;28:689-703. View abstract.
  111. Lin, J., Cook, N. R., Albert, C., Zaharris, E., Gaziano, J. M., Van, Denburgh M., Buring, J. E., and Manson, J. E. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J.Natl.Cancer Inst. 1-7-2009;101:14-23. View abstract.
  112. Zhang, Y., Coogan, P., Palmer, J. R., Strom, B. L., and Rosenberg, L. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control 2009;20:691-698. View abstract.
  113. Bandera, E. V., Gifkins, D. M., Moore, D. F., McCullough, M. L., and Kushi, L. H. Antioxidant vitamins and the risk of endometrial cancer: a dose-response meta-analysis. Cancer Causes Control 2009;20:699-711. View abstract.
  114. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J., and Gaziano, J. M. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 11-12-2008;300:2123-2133. View abstract.
  115. Arnlov, J., Zethelius, B., Riserus, U., Basu, S., Berne, C., Vessby, B., Alfthan, G., and Helmersson, J. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study. Diabetologia 2009;52:97-105. View abstract.
  116. Honarbakhsh, S. and Schachter, M. Vitamins and cardiovascular disease. Br.J.Nutr. 2009;101:1113-1131. View abstract.
  117. Gallicchio, L., Boyd, K., Matanoski, G., Tao, X. G., Chen, L., Lam, T. K., Shiels, M., Hammond, E., Robinson, K. A., Caulfield, L. E., Herman, J. G., Guallar, E., and Alberg, A. J. Carotenoids and the risk of developing lung cancer: a systematic review. Am.J.Clin.Nutr. 2008;88:372-383. View abstract.
  118. Bjelakovic, G., Nikolova, D., Simonetti, R. G., and Gluud, C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane.Database.Syst.Rev. 2008;:CD004183. View abstract.
  119. Loane, E., Kelliher, C., Beatty, S., and Nolan, J. M. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br.J.Ophthalmol. 2008;92:1163-1168. View abstract.
  120. Tanvetyanon, T. and Bepler, G. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands. Cancer 7-1-2008;113:150-157. View abstract.
  121. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., and Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane.Database.Syst.Rev. 2008;:CD007176. View abstract.
  122. Evans, J. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond) 2008;22:751-760. View abstract.
  123. Gao, J., Gao, X., Li, W., Zhu, Y., and Thompson, P. J. Observational studies on the effect of dietary antioxidants on asthma: a meta-analysis. Respirology. 2008;13:528-536. View abstract.
  124. Ye, Z. and Song, H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur.J.Cardiovasc.Prev.Rehabil. 2008;15:26-34. View abstract.
  125. O'Neil, C., Shevill, E., and Chang, A. B. Vitamin A supplementation for cystic fibrosis. Cochrane.Database.Syst.Rev. 2008;:CD006751. View abstract.
  126. Evans, J. R. and Henshaw, K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane.Database.Syst.Rev. 2008;:CD000253. View abstract.
  127. Bardia, A., Tleyjeh, I. M., Cerhan, J. R., Sood, A. K., Limburg, P. J., Erwin, P. J., and Montori, V. M. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin.Proc. 2008;83:23-34. View abstract.
  128. Kopcke, W. and Krutmann, J. Protection from sunburn with beta-Carotene--a meta-analysis. Photochem.Photobiol. 2008;84:284-288. View abstract.
  129. Jones, A. A. Age related macular degeneration--should your patients be taking additional supplements? Aust.Fam.Physician 2007;36:1026-1028. View abstract.
  130. Christen, W. G., Glynn, R. J., Chew, E. Y., and Buring, J. E. Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology 2008;115:822-829. View abstract.
  131. Grieger, J. A., Nowson, C. A., Jarman, H. F., Malon, R., and Ackland, L. M. Multivitamin supplementation improves nutritional status and bone quality in aged care residents. Eur.J.Clin.Nutr. 2009;63:558-565. View abstract.
  132. Grodstein, F., Kang, J. H., Glynn, R. J., Cook, N. R., and Gaziano, J. M. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch.Intern.Med. 11-12-2007;167:2184-2190. View abstract.
  133. Werneke, U. Risk management of nutritional supplements in chronic illness: the implications for the care of cancer and depression. Proc.Nutr.Soc. 2007;66:483-492. View abstract.
  134. Bath-Hextall, F., Leonardi-Bee, J., Somchand, N., Webster, A., Delitt, J., and Perkins, W. Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane.Database.Syst.Rev. 2007;:CD005414. View abstract.
  135. Chong, E. W., Wong, T. Y., Kreis, A. J., Simpson, J. A., and Guymer, R. H. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 10-13-2007;335:755. View abstract.
  136. Gray, J., Mao, J. T., Szabo, E., Kelley, M., Kurie, J., and Bepler, G. Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest 2007;132(3 Suppl):56S-68S. View abstract.
  137. Hercberg, S., Ezzedine, K., Guinot, C., Preziosi, P., Galan, P., Bertrais, S., Estaquio, C., Briancon, S., Favier, A., Latreille, J., and Malvy, D. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J.Nutr. 2007;137:2098-2105. View abstract.
  138. Cook, N. R., Albert, C. M., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., and Manson, J. E. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch.Intern.Med. 8-13-2007;167:1610-1618. View abstract.
  139. Kubo, A. and Corley, D. A. Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am.J.Gastroenterol. 2007;102:2323-2330. View abstract.
  140. Michels, K. B., Mohllajee, A. P., Roset-Bahmanyar, E., Beehler, G. P., and Moysich, K. B. Diet and breast cancer: a review of the prospective observational studies. Cancer 6-15-2007;109(12 Suppl):2712-2749. View abstract.
  141. Von Low, E. C., Perabo, F. G., Siener, R., and Muller, S. C. Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In Vivo 2007;21:189-204. View abstract.
  142. No author. NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Consens.State Sci.Statements. 5-15-2006;23:1-30. View abstract.
  143. Wright, M. E., Virtamo, J., Hartman, A. M., Pietinen, P., Edwards, B. K., Taylor, P. R., Huttunen, J. K., and Albanes, D. Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial. Cancer 3-1-2007;109:891-898. View abstract.
  144. Liu, B. A., McGeer, A., McArthur, M. A., Simor, A. E., Aghdassi, E., Davis, L., and Allard, J. P. Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: a randomized, placebo-controlled study. J.Am.Geriatr.Soc. 2007;55:35-42. View abstract.
  145. Plummer, M., Vivas, J., Lopez, G., Bravo, J. C., Peraza, S., Carillo, E., Cano, E., Castro, D., Andrade, O., Sanchez, V., Garcia, R., Buiatti, E., Aebischer, C., Franceschi, S., Oliver, W., and Munoz, N. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J.Natl.Cancer Inst. 1-17-2007;99:137-146. View abstract.
  146. Greenwald, P., Anderson, D., Nelson, S. A., and Taylor, P. R. Clinical trials of vitamin and mineral supplements for cancer prevention. Am.J.Clin.Nutr. 2007;85:314S-317S. View abstract.
  147. Seddon, J. M. Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract. Am.J.Clin.Nutr. 2007;85:304S-307S. View abstract.
  148. Mannisto, S., Yaun, S. S., Hunter, D. J., Spiegelman, D., Adami, H. O., Albanes, D., van den Brandt, P. A., Buring, J. E., Cerhan, J. R., Colditz, G. A., Freudenheim, J. L., Fuchs, C. S., Giovannucci, E., Goldbohm, R. A., Harnack, L., Leitzmann, M., McCullough, M. L., Miller, A. B., Rohan, T. E., Schatzkin, A., Virtamo, J., Willett, W. C., Wolk, A., Zhang, S. M., and Smith-Warner, S. A. Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am J Epidemiol. 2-1-2007;165:246-255. View abstract.
  149. Lodi, G., Sardella, A., Bez, C., Demarosi, F., and Carrassi, A. Interventions for treating oral leukoplakia. Cochrane.Database.Syst.Rev. 2006;:CD001829. View abstract.
  150. Bleys, J., Miller, E. R., III, Pastor-Barriuso, R., Appel, L. J., and Guallar, E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am.J Clin.Nutr 2006;84:880-887. View abstract.
  151. Kamangar, F., Qiao, Y. L., Yu, B., Sun, X. D., Abnet, C. C., Fan, J. H., Mark, S. D., Zhao, P., Dawsey, S. M., and Taylor, P. R. Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, China. Cancer Epidemiol.Biomarkers Prev. 2006;15:1562-1564. View abstract.
  152. Huang, H. Y., Caballero, B., Chang, S., Alberg, A. J., Semba, R. D., Schneyer, C. R., Wilson, R. F., Cheng, T. Y., Vassy, J., Prokopowicz, G., Barnes, G. J., and Bass, E. B. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann.Intern.Med. 9-5-2006;145:372-385. View abstract.
  153. Chiu, C. J. and Taylor, A. Nutritional antioxidants and age-related cataract and maculopathy. Exp.Eye Res. 2007;84:229-245. View abstract.
  154. Bjelakovic, G., Nagorni, A., Nikolova, D., Simonetti, R. G., Bjelakovic, M., and Gluud, C. Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment.Pharmacol Ther 7-15-2006;24:281-291. View abstract.
  155. Coulter, I. D., Hardy, M. L., Morton, S. C., Hilton, L. G., Tu, W., Valentine, D., and Shekelle, P. G. Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen.Intern Med 2006;21:735-744. View abstract.
  156. Worthington, H. V., Clarkson, J. E., and Eden, O. B. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane.Database.Syst.Rev. 2006;:CD000978. View abstract.
  157. Evans, J. R. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane.Database.Syst.Rev 2006;:CD000254. View abstract.
  158. Gritz, D. C., Srinivasan, M., Smith, S. D., Kim, U., Lietman, T. M., Wilkins, J. H., Priyadharshini, B., John, R. K., Aravind, S., Prajna, N. V., Duraisami, Thulasiraj R., and Whitcher, J. P. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006;90:847-851. View abstract.
  159. Woodside, J. V., McCall, D., McGartland, C., and Young, I. S. Micronutrients: dietary intake v. supplement use. Proc Nutr Soc 2005;64:543-553. View abstract.
  160. Irlam, J. H., Visser, M. E., Rollins, N., and Siegfried, N. Micronutrient supplementation in children and adults with HIV infection. Cochrane.Database.Syst.Rev 2005;:CD003650. View abstract.
  161. Cho, E., Hunter, D. J., Spiegelman, D., Albanes, D., Beeson, W. L., van den Brandt, P. A., Colditz, G. A., Feskanich, D., Folsom, A. R., Fraser, G. E., Freudenheim, J. L., Giovannucci, E., Goldbohm, R. A., Graham, S., Miller, A. B., Rohan, T. E., Sellers, T. A., Virtamo, J., Willett, W. C., and Smith-Warner, S. A. Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int.J.Cancer 2-15-2006;118:970-978. View abstract.
  162. McNaughton, S. A., Marks, G. C., and Green, A. C. Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin. Cancer Epidemiol.Biomarkers Prev. 2005;14:1596-1607. View abstract.
  163. Ovesen, L. F. [Increased consumption of fruits and vegetables reduces the risk of ischemic heart disease]. Ugeskr.Laeger 6-20-2005;167(25-31):2742-2747. View abstract.
  164. Finley, J. W. Proposed criteria for assessing the efficacy of cancer reduction by plant foods enriched in carotenoids, glucosinolates, polyphenols and selenocompounds. Ann.Bot. 2005;95:1075-1096. View abstract.
  165. Christen, W., Glynn, R., Sperduto, R., Chew, E., and Buring, J. Age-related cataract in a randomized trial of beta-carotene in women. Ophthalmic Epidemiol. 2004;11:401-412. View abstract.
  166. Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Meyskens, F. L., Jr., Omenn, G. S., Valanis, B., and Williams, J. H., Jr. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J.Natl.Cancer Inst. 12-1-2004;96:1743-1750. View abstract.
  167. Dijkhuizen, M. A., Wieringa, F. T., West, C. E., and Muhilal. Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants. Am.J.Clin.Nutr. 2004;80:1299-1307. View abstract.
  168. McArdle, F., Rhodes, L. E., Parslew, R. A., Close, G. L., Jack, C. I., Friedmann, P. S., and Jackson, M. J. Effects of oral vitamin E and beta-carotene supplementation on ultraviolet radiation-induced oxidative stress in human skin. Am.J.Clin.Nutr. 2004;80:1270-1275. View abstract.
  169. Bjelakovic, G., Nikolova, D., Simonetti, R. G., and Gluud, C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane.Database.Syst.Rev. 2004;:CD004183. View abstract.
  170. Lodi, G., Sardella, A., Bez, C., Demarosi, F., and Carrassi, A. Interventions for treating oral leukoplakia. Cochrane.Database.Syst.Rev. 2004;:CD001829. View abstract.
  171. McKeever, T. M. and Britton, J. Diet and asthma. Am.J.Respir.Crit Care Med. 10-1-2004;170:725-729. View abstract.
  172. Tornwall, M. E., Virtamo, J., Korhonen, P. A., Virtanen, M. J., Albanes, D., and Huttunen, J. K. Postintervention effect of alpha tocopherol and beta carotene on different strokes: a 6-year follow-up of the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. Stroke 2004;35:1908-1913. View abstract.
  173. Schaumberg, D. A., Frieling, U. M., Rifai, N., and Cook, N. No effect of beta-carotene supplementation on risk of nonmelanoma skin cancer among men with low baseline plasma beta-carotene. Cancer Epidemiol.Biomarkers Prev. 2004;13:1079-1080. View abstract.
  174. Cardinault, N., Tyssandier, V., Grolier, P., Winklhofer-Roob, B. M., Ribalta, J., Bouteloup-Demange, C., Rock, E., and Borel, P. Comparison of the postprandial chylomicron carotenoid responses in young and older subjects. Eur.J.Nutr. 2003;42:315-323. View abstract.
  175. Hemila, H., Virtamo, J., Albanes, D., and Kaprio, J. Physical activity and the common cold in men administered vitamin E and beta-carotene. Med.Sci.Sports Exerc. 2003;35:1815-1820. View abstract.
  176. Toma, S., Bonelli, L., Sartoris, A., Mira, E., Antonelli, A., Beatrice, F., Giordano, C., Benazzo, M., Caroggio, A., Cavalot, A. L., Gandolfo, S., Garozzo, A., Margarino, G., Schenone, G., Spadini, N., Zibordi, F., Balzarini, F., Serafini, I., Miani, P., and Cortesina, G. beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial. Oncol.Rep. 2003;10:1895-1901. View abstract.
  177. Shibata, A., Paganini-Hill, A., Ross, R. K., and Henderson, B. E. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br.J.Cancer 1992;66:673-679. View abstract.
  178. Chandra, R. K. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 11-7-1992;340:1124-1127. View abstract.
  179. Bayerl, C., Schwarz, B., and Jung, E. G. A three-year randomized trial in patients with dysplastic naevi treated with oral beta-carotene. Acta Derm.Venereol. 2003;83:277-281. View abstract.
  180. Sasazuki, S., Sasaki, S., Tsubono, Y., Okubo, S., Hayashi, M., Kakizoe, T., and Tsugane, S. The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection. Cancer Sci. 2003;94:378-382. View abstract.
  181. Baron, J. A., Cole, B. F., Mott, L., Haile, R., Grau, M., Church, T. R., Beck, G. J., and Greenberg, E. R. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J.Natl.Cancer Inst. 5-21-2003;95:717-722. View abstract.
  182. Darlington, S., Williams, G., Neale, R., Frost, C., and Green, A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch.Dermatol. 2003;139:451-455. View abstract.
  183. Zhu, S., Mason, J., Shi, Y., Hu, Y., Li, R., Wahg, M., Zhou, Y., Jin, G., Xie, Y., Wu, G., Xia, D., Qian, Z., Sohg, H., Zhang, L., Russell, R., and Xiao, S. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med.J.(Engl.) 2003;116:15-19. View abstract.
  184. Christen, W. G., Manson, J. E., Glynn, R. J., Gaziano, J. M., Sperduto, R. D., Buring, J. E., and Hennekens, C. H. A randomized trial of beta carotene and age-related cataract in US physicians. Arch.Ophthalmol. 2003;121:372-378. View abstract.
  185. Heinrich, U., Gartner, C., Wiebusch, M., Eichler, O., Sies, H., Tronnier, H., and Stahl, W. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. J Nutr 2003;133:98-101. View abstract.
  186. Wood, L. G., Fitzgerald, D. A., Lee, A. K., and Garg, M. L. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am.J.Clin.Nutr. 2003;77:150-159. View abstract.
  187. Prince, M. I., Mitchison, H. C., Ashley, D., Burke, D. A., Edwards, N., Bramble, M. G., James, O. F., and Jones, D. E. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment.Pharmacol.Ther. 2003;17:137-143. View abstract.
  188. Michaud, D. S., Pietinen, P., Taylor, P. R., Virtanen, M., Virtamo, J., and Albanes, D. Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br.J.Cancer 10-21-2002;87:960-965. View abstract.
  189. Thurmann, P. A., Steffen, J., Zwernemann, C., Aebischer, C. P., Cohn, W., Wendt, G., and Schalch, W. Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder. Eur J Nutr 2002;41:228-235. View abstract.
  190. Malila, N., Taylor, P. R., Virtanen, M. J., Korhonen, P., Huttunen, J. K., Albanes, D., and Virtamo, J. Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). Cancer Causes Control 2002;13:617-623. View abstract.
  191. Greul, A. K., Grundmann, J. U., Heinrich, F., Pfitzner, I., Bernhardt, J., Ambach, A., Biesalski, H. K., and Gollnick, H. Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl.Skin Physiol 2002;15:307-315. View abstract.
  192. Cobanoglu, N., Ozcelik, U., Gocmen, A., Kiper, N., and Dogru, D. Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatr. 2002;91:793-798. View abstract.
  193. Schuurman, A. G., Goldbohm, R. A., Brants, H. A., and van den Brandt, P. A. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 2002;13:573-582. View abstract.
  194. Watters, J. M., Vallerand, A., Kirkpatrick, S. M., Abbott, H. E., Norris, S., Wells, G., and Barber, G. G. Limited effects of micronutrient supplementation on strength and physical function after abdominal aortic aneurysmectomy. Clin.Nutr. 2002;21:321-327. View abstract.
  195. No author. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 7-6-2002;360:23-33. View abstract.
  196. Schmidt, M. C., Askew, E. W., Roberts, D. E., Prior, R. L., Ensign, W. Y., Jr., and Hesslink, R. E., Jr. Oxidative stress in humans training in a cold, moderate altitude environment and their response to a phytochemical antioxidant supplement. Wilderness.Environ.Med. 2002;13:94-105. View abstract.
  197. Malila, N., Virtamo, J., Virtanen, M., Pietinen, P., Albanes, D., and Teppo, L. Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers. Eur.J.Clin.Nutr. 2002;56:615-621. View abstract.
  198. Sackett, C. S. and Schenning, S. The age-related eye disease study: the results of the clinical trial. Insight. 2002;27:5-7. View abstract.
  199. McKechnie, R., Rubenfire, M., and Mosca, L. Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease. J.Lab Clin.Med. 2002;139:133-139. View abstract.
  200. Schroder, H., Navarro, E., Mora, J., Galiano, D., and Tramullas, A. Effects of alpha-tocopherol, beta-carotene and ascorbic acid on oxidative, hormonal and enzymatic exercise stress markers in habitual training activity of professional basketball players. Eur.J.Nutr. 2001;40:178-184. View abstract.
  201. Tauler, P., Aguilo, A., Fuentespina, E., Tur, J. A., and Pons, A. Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes. Pflugers Arch. 2002;443(5-6):791-797. View abstract.
  202. Lee, I. M., Cook, N. R., Manson, J. E., and Buring, J. E. Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level? Br.J.Cancer 3-4-2002;86:698-701. View abstract.
  203. Ma, A., Duthie, S. J., Ross, M. A., and Collins, A. R. [Effects of vitamins E, C and beta-carotene on DNA damage]. Zhonghua Yu Fang Yi.Xue.Za Zhi. 1999;33:16-17. View abstract.
  204. Kockar, C., Ozturk, M., and Bavbek, N. Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin. Acta Medica.(Hradec.Kralove) 2001;44:97-100. View abstract.
  205. Ruiz, B., Garay, J., Correa, P., Fontham, E. T., Bravo, J. C., Bravo, L. E., Realpe, J. L., and Mera, R. Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am.J.Gastroenterol. 2001;96:3281-3287. View abstract.
  206. Kennedy-Oji, C., Coutsoudis, A., Kuhn, L., Pillay, K., Mburu, A., Stein, Z., and Coovadia, H. Effects of vitamin A supplementation during pregnancy and early lactation on body weight of South African HIV-infected women. J.Health Popul.Nutr. 2001;19:167-176. View abstract.
  207. Meijer, E. P., Goris, A. H., Senden, J., van Dongen, J. L., Bast, A., and Westerterp, K. R. Antioxidant supplementation and exercise-induced oxidative stress in the 60-year-old as measured by antipyrine hydroxylates. Br.J.Nutr. 2001;86:569-575. View abstract.
  208. Keefe, K. A., Schell, M. J., Brewer, C., McHale, M., Brewster, W., Chapman, J. A., Rose, G. S., McMeeken, D. S., Lagerberg, W., Peng, Y. M., Wilczynski, S. P., Anton-Culver, H., Meyskens, F. L., and Berman, M. L. A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. Cancer Epidemiol.Biomarkers Prev. 2001;10:1029-1035. View abstract.
  209. Hininger, I. A., Meyer-Wenger, A., Moser, U., Wright, A., Southon, S., Thurnham, D., Chopra, M., van den, Berg H., Olmedilla, B., Favier, A. E., and Roussel, A. M. No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr 2001;20:232-238. View abstract.
  210. You, W. C., Chang, Y. S., Heinrich, J., Ma, J. L., Liu, W. D., Zhang, L., Brown, L. M., Yang, C. S., Gail, M. H., Fraumeni, J. F., Jr., and Xu, G. W. An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur.J.Cancer Prev. 2001;10:257-263. View abstract.
  211. Tornwall, M. E., Virtamo, J., Haukka, J. K., Albanes, D., and Huttunen, J. K. Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial. Atherosclerosis 2001;157:167-173. View abstract.
  212. Mayne, S. T., Cartmel, B., Baum, M., Shor-Posner, G., Fallon, B. G., Briskin, K., Bean, J., Zheng, T., Cooper, D., Friedman, C., and Goodwin, W. J., Jr. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Cancer Res. 2-15-2001;61:1457-1463. View abstract.
  213. Jacobson, J. S., Begg, M. D., Wang, L. W., Wang, Q., Agarwal, M., Norkus, E., Singh, V. N., Young, T. L., Yang, D., and Santella, R. M. Effects of a 6-month vitamin intervention on DNA damage in heavy smokers. Cancer Epidemiol.Biomarkers Prev. 2000;9:1303-1311. View abstract.
  214. Renner, S., Rath, R., Rust, P., Lehr, S., Frischer, T., Elmadfa, I., and Eichler, I. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax 2001;56:48-52. View abstract.
  215. Chan, J. M., Pietinen, P., Virtanen, M., Malila, N., Tangrea, J., Albanes, D., and Virtamo, J. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 2000;11:859-867. View abstract.
  216. Lee, J., Jiang, S., Levine, N., and Watson, R. R. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc.Soc.Exp.Biol.Med. 2000;223:170-174. View abstract.
  217. Beckert, E. and Metz, J. [Erythropoietic protoporthyria. Clinical aspects and therapy]. Fortschr.Med. 12-2-1976;94:1981-6, 1995. View abstract.
  218. Lee, T. and Dugoua, J. J. Nutritional supplements and their effect on glucose control. Curr.Diab.Rep. 2011;11:142-148. View abstract.
  219. Worthington, H. V., Clarkson, J. E., and Eden, O. B. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane.Database.Syst.Rev. 2007;:CD000978. View abstract.
  220. Jula, A., Marniemi, J., Huupponen, R., Virtanen, A., Rastas, M., and Ronnemaa, T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA 2-6-2002;287:598-605. View abstract.
  221. Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007;99:754-64. View abstract.
  222. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842-57. View abstract.
  223. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-83. View abstract.
  224. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005;294:3101-7. View abstract.
  225. Meyer F, Galan P, Douville P, et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 2005;116:182-6. View abstract.
  226. Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 2004;93:1139-50. View abstract.
  227. Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006;98:245-54. View abstract.
  228. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42. View abstract.
  229. Knekt P, Ritz J, Pereira MA, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004;80:1508-20. View abstract.
  230. Nesaretnam K, Radhakrishnan A, Selvaduray KR, et al. Effect of palm oil carotene on breast cancer tumorigenicity in nude mice. Lipids 2002;37:557-60. View abstract.
  231. Radhika MS, Bhaskaram P, Balakrishna N, Ramalakshmi BA. Red palm oil supplementation: a feasible diet-based approach to improve vitamin A status of pregnant women and their infants. Food Nutr Bull 2003;24:208-17. View abstract.
  232. Cho E, Seddon JM, Rosner B, et al. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 2004;122:883-92. View abstract.
  233. Cesari M, Pahor M, Bartali B, et al. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr 2004;79:289-94. View abstract.
  234. Montonen J, Knekt P, Jarvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004;27:362-6. View abstract.
  235. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial. JAMA 2005;294:56-65. View abstract.
  236. Cook NR, Le IM, Manson JE, et al. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control 2000;11:617-26. View abstract.
  237. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004;364:1219-28. View abstract.
  238. Kris-Etherton PM, Lichtenstein AH, Howard BV, et al. AHA Science Advisory: Antioxidant vitamin supplements and cardiovascular disease. Circulation 2004;110:637-41. View abstract.
  239. Kennedy DD, Tucker KL, Ladas ED, et al. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr 2004;79:1029-36. View abstract.
  240. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degermation: the Veterans LAST study (Lutein Antioxidant Supplement Trial). Optometry 2004;75:216-30. View abstract.
  241. Mathews-Roth MM. Treatment of the cutaneous porphyrias. Clin Dermatol 1998;16:295-8. View abstract.
  242. Biesalski HK, Obermueller-Jevic UC. UV light, beta-carotene and human skin--beneficial and potentially harmful effects. Arch Biochem Biophys 2001;389:1-6. View abstract.
  243. Food Standards Agency. Medicines and Healthcare products Regulatory Agency (MHRA). Expert Group on Vitamins and Minerals. Available at: http://cot.food.gov.uk/sites/default/files/vitmin2003.pdf.
  244. Cheung MC, Zhao XQ, Chait A, et al. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol 2001;21:1320-6. View abstract.
  245. Age-Related Eye Disease Study Research Group. Potential public health impact of age-related eye disease study results: AREDS report no. 11. Arch Ophthalmol 2003;121:1621-4. View abstract.
  246. Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003;290:476-85.. View abstract.
  247. Darlington S, Williams G, Neale R, et al. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003;139:451-5. View abstract.
  248. Tardif JC. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997;337:365-372.. View abstract.
  249. Chylack LT, Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): A randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002;9:49-80.. View abstract.
  250. Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 2000;36:636-46.. View abstract.
  251. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 2002;288:715-21. View abstract.
  252. Levi F, Pasche C, Lucchini F, La Vecchia C. Selected micronutrients and colorectal cancer: a case-control study from the canton of Vaud, Switzerland. Eur J Cancer 2000;36:2115-9. View abstract.
  253. Yeum KJ, Ahn SH, Rupp de Paiva SA, et al. Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer. J Nutr 1998;128:1920-6.. View abstract.
  254. Fuller CJ, Butterfoss DN, Failla ML. Relative bioavailability of beta-carotene from supplement sources. Nutr Res 2001;21:1209-15.
  255. Erlinger TP, Guallar E, Miller ER, et al. Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch Intern Med 2001;161:1903-8.. View abstract.
  256. Albanes D, Virtamo J, Taylor PR, et al. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1997;66:366-72.. View abstract.
  257. Cramer DW, Kuper H, Harlow BL, Titus-Ernstoff L. Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women. Int J Cancer 94:128-34.. View abstract.
  258. Kim MK, Ahn SH, Lee-Kim. Relationship of serum alpha-tocopherol, carotenoids and retinol with the risk of breast cancer. Nutr Res 2001;21:797-809.
  259. Luchsinger JA, Tang M, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003;60:203-8.. View abstract.
  260. Klipstein-Grobusch K, den Breeijen JH, Grobbee DE, et al. Dietary antioxidants and peripheral arterial disease: the Rotterdam study. Am J Epidemiol 2001;154:145-9.. View abstract.
  261. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33.. View abstract.
  262. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98-107. View abstract.
  263. Christian P, Khatry SK, Yamini S, et al. Zinc supplementation might potentiate the effect of vitamin A in restoring night vision in pregnant Nepalese women. Am J Clin Nutr 2001;73:1045-51. View abstract.
  264. Kumar B, Cole WC, Prasad KN. Alpha tocopheryl succinate, retinoic acid and polar carotenoids enhanced the growth-inhibitory effect of a cholesterol-lowering drug on immortalized and transformed nerve cells in culture. J Am Coll Nutr 2001;20:628-36. View abstract.
  265. Prakash P, Russell RM, Krinsky NI. In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. J Nutr 2001;131:1574-80. View abstract.
  266. Hickenbottom SJ, Follett JR, Lin Y, et al. Variability in conversion of beta-carotene to vitamin A in men as measured by using a double-tracer study design. Am J Clin Nutr 2002;75:900-7. View abstract.
  267. Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Prostate cancer and dietary carotenoids. Am J Epidemiol 2000;151:119-23. View abstract.
  268. Elsayed NM, Bendich A. Dietary antioxidants: potential effects on oxidative products in cigarette smoke. Nutr Res 2001;21:551-67.
  269. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996;156:637-42. View abstract.
  270. Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9. View abstract.
  271. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Investig 1993;71:3-6. View abstract.
  272. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-93. View abstract.
  273. Todd S, Woodward M, Tunstall-Pedoe H, Bolton-Smith C. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish Heart Health Study. Am J Epidemiol 1999;150:1073-80. View abstract.
  274. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69:261-6. View abstract.
  275. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439-52. View abstract.
  276. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36. View abstract.
  277. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002. Available at: www.nap.edu/books/0309072794/html/.
  278. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1225-35. View abstract.
  279. Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol 1988;106:192-8. View abstract.
  280. Girodon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized, controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999;159:748-54. View abstract.
  281. Pryor WA, Stahl W, Rock CL. Beta carotene: from biochemistry to clinical trials. Nutr Rev 2000;58:39-53. View abstract.
  282. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9. View abstract.
  283. Russell RM. The vitamin A spectrum: from deficiency to toxicity. Am J Clin Nutr 2000;71:878-84. View abstract.
  284. Christian P, West KP Jr, Khatry SK, et al. Vitamin A or beta-carotene supplementation reduces but does not eliminate maternal night blindness in Nepal. J Nutr 1998;128:1458-63. View abstract.
  285. West KP Jr, Katz J, Khatry SK, et al. Double-blind cluster, randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 Study Group. BMJ 1999;318:570-5. View abstract.
  286. Katz J, West KP Jr, Khatry SK, et al. Maternal low-dose vitamin A or {beta}-carotene supplementation has no effect on fetal loss and early infant mortality: a randomized, cluster trial in Nepal. Am J Clin Nutr 2000;71:1570-6. View abstract.
  287. Stahl W, Heinrich U, Jungmann H, et al. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am J Clin Nutr 2000;71:795-8. View abstract.
  288. Roodenburg AJ, Leenen R, van het Hof KH, et al. Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans. Am J Clin Nutr 2000;71:1187-93. View abstract.
  289. Roche Laboratories, Inc. Package insert for Xenical. April 1999.
  290. Seddon JM, Ajani UA, Sperduto R, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994;272:1413-20. View abstract.
  291. Ehrenfeld M, Levy M, Sharon P, et al. Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (Familial Mediterranean Fever). Dig Dis Sci 1982;27:723-7. View abstract.
  292. Matsui MS, Rozovski SJ. Drug-nutrient interaction. Clin Ther 1982;4:423-40. View abstract.
  293. Jacobson ED, Faloon WW. Malasorptive effects of neomycin in commonly used doses. JAMA 1961;175:187-90. View abstract.
  294. McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39:648-56. View abstract.
  295. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000. Available at: http://www.nap.edu/books/0309069351/html/.
  296. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 1998;76:224-9. View abstract.
  297. Teikari JM, Rautalahti M, Haukka J, et al. Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements. J Epidemiol Community Health 1998;52:468-72. View abstract.
  298. Hartman TJ, Albanes D, Pietinen P, et al. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 1998;7:335-40. View abstract.
  299. Race TF, Paes IC, Faloon WW. Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. Am J Med Sci 1970;259:32-41. View abstract.
  300. Clark JH, Russell GJ, Fitzgerald JF, et al. Serum beta-carotene, retinol, and alpha-tocopherol levels during mineral oil therapy for constipation. Am J Dis Child 1987;141:1210-2. View abstract.
  301. Becker GL. The case against mineral oil. Am J Digestive Dis 1952;19:344-8. View abstract.
  302. Tonstad S, Silverstein M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolemia. Arch Dis Child 1996;74:157-60. View abstract.
  303. Knodel LC, Talbert RL. Adverse effects of hypolipidaemic drugs. Med Toxicol 1987;2:10-32. View abstract.
  304. Elinder LS, Hadell K, Johansson J, et al. Probucol treatment decreases serum concentrations of diet-derived antioxidants. Arterioscler Thromb Vasc Biol 1995;15:1057-63. View abstract.
  305. Hathcock JN. Metabolic mechanisms of drug-nutrient interactions. Fed Proc 1985;44:124-9. View abstract.
  306. Slattery ML, Benson J, Curtin K, et al. Carotenoids and colon cancer. Am J Clin Nutr 2000;71:575-82. View abstract.
  307. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6. View abstract.
  308. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994;331:141-7. View abstract.
  309. Malila N, Virtamo J, Virtanen M, et al. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 1999;8:489-93. View abstract.
  310. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35. View abstract.
  311. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715-20. View abstract.
  312. Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998;158:668-75. View abstract.
  313. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6. View abstract.
  314. Leppala JM, Virtamo J, Fogelholm R, et al. Vitamin E and Beta Carotene supplementation in high risk for stroke: a subgroup analysis of the alpha-tocopherol, beta-carotene cancer prevention study. Arch Neurol 2000;57:1503-9. View abstract.
  315. Blot WJ, Li JY, Taylor PR. Nutritional intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92. View abstract.
  316. Greenberg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996;275:699-703. View abstract.
  317. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9. View abstract.
  318. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5. View abstract.
  319. Patrick L. Beta-carotene: the controversy continues. Alt Med Rev 2000;5:530-45. View abstract.
  320. Green A, Williams G, Neale R, et al. Daily sunscreen applications and beta-carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 1999;354:723-9. View abstract.
  321. Alberg AJ, Chen JC, Zhao H, et al. Household exposure to passive cigarette smoking and serum micronutrient concentrations. Am J Clin Nutr 2000;72:1576-82. View abstract.
  322. van der Vliet A. Cigarettes, cancer and the carotenoids: a continuing, unresolved antioxidant paradox. Am J Clin Nutr 2000;72:1421-3. View abstract.
  323. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of baseline characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70. View abstract.
  324. Christian P, West KP, Khatry SK, et al. Vitamin A or beta-carotene supplementation reduces symptoms of illness in pregnant and lactating Nepali women. J Nutr 2000;130:2675-82. View abstract.
  325. Rautalahti M, Virtamo J, Haukka J, et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am J Respir Crit Care Med 1997;156:1447-52. View abstract.
  326. Correa P, Fontham ETH, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-8. View abstract.
  327. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76. View abstract.
  328. Koonsvitsky BP, Berry DA, et al. Olestra affects serum concentrations of alpha-tocopherol and carotenoids but not vitamin D or vitamin K status in free-living subjects. J Nutr 1997;127:1636S-45S. View abstract.
  329. Neuman I, Nahum H, Ben-Amotz A. Prevention of exercise-induced asthma by a natural isomer mixture of beta-carotene. Ann Allergy Asthma Immunol 1999;82:549-53. View abstract.
  330. Cook NR, Stampfer MJ, Ma J, et al. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 1999;86:1783-92. View abstract.
  331. Garewal HS, Katz RV, Meyskens F, et al. Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial. Arch Otolaryngol Head Neck Surg 1999;125:1305-10. View abstract.
  332. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and lung cancer: a review of recent research. Nutr Rev 1999;57:133-45. View abstract.
  333. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutr Rev 1999;57:201-14. View abstract.
  334. Lee IM, Cook NR, Manson JE, et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999;91:2102-6. View abstract.
  335. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59:1225-30. View abstract.
  336. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 1999;91:547-56. View abstract.
  337. Tribble DL. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association. Circulation 1999;99:591-5. View abstract.
  338. Leppala JM, Virtamo J, Fogelholm R, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 2000;20:230-5. View abstract.
  339. Frieling UM, Schaumberg DA, Kupper TS, et al. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physicians' health study. Arch Dermatol 2000;136:179-84. View abstract.
  340. Daviglus ML, Dyer AR, Persky V, et al. Dietary beta-carotene, vitamin C, and risk of prostate cancer: results from the Western Electric Study. Epidemiology 1996;7:472-7. View abstract.
  341. Giuliano AR, Gapstur S. Can cervical dysplasia and cancer be prevented with nutrients? Nutr Rev 1998;56:9-16. View abstract.
  342. Omenn GS. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health 1998;19:73-99. View abstract.
  343. Tang G, Serfaty-Lacrosniere C, Camilo ME, et al. Gastric acidity influences the blood response to a beta-carotene dose in humans. Am J Clin Nutr 1996;64:622-6. View abstract.
Last reviewed - 05/12/2017